2022
DOI: 10.32604/oncologie.2022.024035
|View full text |Cite
|
Sign up to set email alerts
|

The Interface of Cancer, Their Microenvironment and Nanotechnology

Abstract: Cancer is one of the deadliest diseases with a cure far from being found. Despite the extraordinary advances in the therapy approaches, only a few patients respond to treatments. The tumor microenvironment (TME) plays a crucial role in cancer progression by contributing to the chemoresistance. Thus, emerging efforts are being made in nanotechnology research focusing on nanoparticles' potential role and their application in immune system modulation. Moreover, the omics have contributed to bioengineering and nan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 260 publications
(290 reference statements)
0
1
0
Order By: Relevance
“…Nevertheless, the recent development of hypoxia-responsive nanoparticles that selectively release their cargo under hypoxic conditions in the TME [323,324] provides a perspective for the specific delivery of the UPR branches inhibitors including 4µ8C for IRE1 [325,326], ISRIB for PERK [327], or Ceapins for ATF6 [328]. This approach would provide an excellent mechanism for the selective analysis of these pathway functions in the context of the hypoxic TME.…”
Section: Discussionmentioning
confidence: 99%
“…Nevertheless, the recent development of hypoxia-responsive nanoparticles that selectively release their cargo under hypoxic conditions in the TME [323,324] provides a perspective for the specific delivery of the UPR branches inhibitors including 4µ8C for IRE1 [325,326], ISRIB for PERK [327], or Ceapins for ATF6 [328]. This approach would provide an excellent mechanism for the selective analysis of these pathway functions in the context of the hypoxic TME.…”
Section: Discussionmentioning
confidence: 99%